LLY

Eli Lilly and Company (LLY), classified in the Health Care sector, has drawn disclosed trading activity from 28 members of Congress across 109 total transactions spanning from March 2022 through June 2026, with purchases outpacing sales 58 to 50. The most active disclosers by trade count include Josh Gottheimer, Ro Khanna, David Taylor, and Dan Newhouse, and the record shows four bipartisan co-trading clusters, each of which spans both chambers of Congress. Thirty-two executive-branch officials have separately disclosed 51 transactions in the same security in public filings, with the closest congressional and executive purchase disclosures falling four days apart — a sequence observed in independent public records. The breadth of participation across parties and chambers reflects a widely held name within the Health Care sector.